Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Investigating tDCS as a Treatment for Unipolar and Bipolar Depression [Phase 2, Phase 3]
This clinical trial update covers phase 2 and phase 3 studies evaluating transcranial direct current stimulation (tDCS) as a treatment for u…
-
FDA approval · 2015-11-30FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Zydus Pharmaceuticals USA Inc. The specific changes covered by th…
-
FDA approval · 2015-11-30FDA Approved: DIVALPROEX SODIUM — Supplemental Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' supplemental application for Divalproex Sodium under ANDA078239, granting approval of a generic product…
-
FDA approval · 2015-11-27FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for olanzapine from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode [Phase 3]
The Phase 3 trial evaluating continuation and maintenance therapy with atypical antipsychotics after an acute manic episode in Bipolar I Dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-19FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ziprasidone from Dr. Reddy's Laboratories Limited, approving a generic version under the AND…
-
CLINICAL_TRIALS research · 2015-11-18Clinical Trial Update: Partnership in Medication Management (PIMM) in Patients With Mood Disorders [NA]
Clinical trial update on Partnership in Medication Management (PIMM) in patients with mood disorders; the status and phase are not provided.
-
FDA approval · 2015-11-05FDA Approved: OLANZAPINE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for the generic olanzapine product manufactured by Macleods Pharmaceuticals Limited under ANDA 20286…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar [Phase 3]
This Clinical Trial Update reports on a Phase 3 study evaluating risperidone and divalproex sodium with MRI assessments in pediatric bipolar…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS) [Phase 1]
A Phase 1 trial investigates whether transcranial direct current stimulation can remediate cognitive dysfunction in euthymic bipolar disorde…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Gao Bipolar Spectrum Lithium/Quetiapine Study [Phase 4]
Phase 4 trial evaluating a lithium/quetiapine combination for bipolar disorder was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants [Phase 1]
Phase 1 pharmacokinetics study of five antipsychotic medications in psychiatric participants has completed.
-
FDA approval · 2015-10-27FDA Approved: LAMOTRIGINE — Original Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s generic lamotrigine under ANDA204158, allowing the generic product to be marketed for the same indications as …
-
FDA approval · 2015-10-22FDA Approved: RISPERIDONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for Risperidone from Jubilant Cadista Pharmaceuticals Inc., signifying an approval related to this g…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Antipsychotics and Risk of Hyperglycemic Emergencies
A completed clinical trial update examining whether antipsychotics are associated with an elevated risk of hyperglycemic emergencies in peop…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
A clinical trial registry study of patients treated with atypical antipsychotics has completed enrollment and is reporting on outcomes acros…
-
FDA approval · 2015-10-20FDA Approved: OLANZAPINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's original application to manufacture and market a generic olanzapine product.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Clinical Study of Light Therapy on Depressive Episodes of Bipolar Disorder [NA]
Completed clinical trial evaluating light therapy for depressive episodes in individuals with bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder [Phase 2]
Phase 2 safety and efficacy study of ELND005 as an adjunctive maintenance treatment in Bipolar I Disorder was terminated; results posted in …
-
CLINICAL_TRIALS research · 2015-10-07Clinical Trial Update: Complex Dynamic Systems in Mood Disorders
An update on a completed clinical trial at Massachusetts General Hospital exploring complex dynamic systems in mood disorders. The condition…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Relapse Prevention for Bipolar Type-II Disorder [Phase 4]
Phase 4 relapse-prevention clinical trial in bipolar disorder (including Bipolar Type II) with co-occurring depression has completed.
-
FDA approval · 2015-10-05FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for the olanzapine and fluoxetine combination (Symbyax) submitted by Par Health USA, LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients [NA]
ClinicalTrials.gov update on a feasibility and tolerability study of adjunct chronotherapy (light therapy) in hospitalized patients with maj…
-
FDA approval · 2015-10-01FDA Tentative Approval: LAMOTRIGINE — Supplemental Application (NorthStar Rx LLC)
FDA tentatively approved NorthStar Rx LLC's generic lamotrigine product under an ANDA.
-
FDA approval · 2015-09-30FDA Approved: ARIPIPRAZOLE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s Original Application for aripiprazole, granting approval of a generic version of the antipsychotic.